A nice problem to have: when ALK inhibitor therapy works better than expected

J Thorac Oncol. 2014 Apr;9(4):433-5. doi: 10.1097/JTO.0000000000000124.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / enzymology
  • Prognosis
  • Protein Kinase Inhibitors / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptor Protein-Tyrosine Kinases / metabolism

Substances

  • Protein Kinase Inhibitors
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases